Skip to main content

People in the News: Jun 4, 2010 (rev. 1)

Premium

Genstruct has appointed David de Graaf as its chief scientific officer.

De Graaf most recently served as vice president of biotherapeutics and integrative biology at Boehringer-Ingelheim. Prior to that, he was director of systems biology at Pfizer and built the first systems biology team at AstraZeneca.

Before his career in industry, de Graaf was a researcher at the Weizmann Institute of Science and the Center for Genome Research at Whitehead/MIT.

Filed under

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.